Bumetanide in refractory ascites of cirrhosis of the liver: a comparison with furosemide.
Bumetanide and furosemide were compared in the treatment of resistant ascites in patients with liver disease of alcoholic origin. In a prospective randomized trial, no significant difference was found in the ability of these two agents to promote natriuresis or diuresis. The duration of action was 12 hours for bumetanide and 6 hours for furosemide, but this difference was of no clinical significance.
D000328:Adult; D000368:Aged; D001201:Ascites / Q000188:drug therapy*; D001835:Body Weight / Q000187:drug effects; D002034:Bumetanide / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004573:Electrolytes / Q000652:urine; D005665:Furosemide / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged
D004232:Diuretics; D004573:Electrolytes; D002034:Bumetanide; D005665:Furosemide